11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours	Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, malignant endocrine neoplasm, neoplasm, primary aldosteronism	Active, not recruiting	Phase 2 / Phase 3	2025-12-02		NCT06100367

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Changi General Hospital	29
Clinical Imaging Research Centre	1
Khoo Teck Puat Hospital	9
National University Health System, Singapore	19
Ng Teng Fong General Hospital	5
Sengkang General Hospital	17
Singapore General Hospital	80
Tan Tock Seng Hospital	33

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Changi General Hospital	Singapore	Singapore	16
Khoo Teck Puat Hospital	Singapore	Singapore	5
National University Hospital	Singapore	Singapore	46
Ng Teng Fong General Hospital	Singapore	Singapore	4
Sengkang General Hospital	Singapore	Singapore	11
Singapore General Hospital	Singapore	Singapore	33
Tan Tock Seng Hospital	Singapore	Singapore	22